This Week
  • GM injection: The automaker has invested $150 million here since 2011.

  • Placing a loved one in an elder care facility is not an easy decision for caregivers.

  • HBT Architects took a risk and parted with some clients on its new path.

  • East High School teacher and blogger Kelly LaLonde speaks out about education.

  • CEO Dawn Smith worked her way up through the ranks at Pace Electronics of Sodus.

  • The new edition of Explore Greater Rochester is here.

Trulign lens by B&L gets FDA approval

Rochester Business Journal
May 21, 2013

Bausch & Lomb Inc. has received U.S. Food and Drug Administration approval for its Trulign lens, company officials said Tuesday.

Meant for cataract and other eye-surgery patients, the Trulign lens corrects astigmatic blurred vision, which can be an unwanted side effect of artificial lens implantation.  According to the eye-care company, it is the first toric intraocular lens that can correct astigmatism and deliver improved vision across a natural range of focus as well.   
 
(c) 2013 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or e-mail service@rbj.net.
 


What You're Saying 

There are no comments yet. Be the first to add yours!

Post Your Own Comment

 
Username:
Password:

Not registered? Sign up now!
 

To Do   Text Size
Post CommentPost A Comment eMail Size1
View CommentsView All Comments PrintPrint Size2
ReprintsReprints Size3
  • E-mailed
  • Commented
  • Viewed
RBJ   Google